ENT Private Equity | Allergy Private Equity | PGP

Private Equity Investment in ENT & Allergy Practices

Overview

Driven by market inefficiency, ancillary opportunity, and broader economic headwinds, healthcare private equity consolidation has been a leading force of change within healthcare for over a century. Starting in the late 1990’s, the primary entity behind this consolidation has been outside investors specifically, healthcare private pquity investors, looking to partner with clinically strong providers and create regional and national platforms. Leveraging size and scale, these private equity funds invest alongside providers in medical specialties such as ENT & Allergy Practices to help grow in existing and new markets.

Intrigued by a fragmented market and the potential for scalability, private equity firms are turning to ENT & allergy practices for new investment opportunities. More physicians are finding themselves spending less time caring for their patients and more time dealing with things like regulatory compliance, insurance preauthorization, personnel and staffing matters, marketing, reimbursement and general back-office challenges. As a result, an increasing number of independent practices are turning to private equity as a solution to handle these issues, while providing the financial horsepower to fuel growth.

Among the most active platforms in the specialty over the last year are Elevate ENT Partners (Audax Group), SENTA (Shore Capital), and ENT Partners (Candescent Partners). PGP anticipates continued sponsor-backed capital will fuel new platforms and bolt-on investments over the next 12-24 months. Notable other platforms include Allergy Partners (Waypoint Capital Partners), Aspire Allergy and Sinus (Source Capital), and Parallel ENT & Allergy (Trinity Hunt Partners).

The Physician Growth Partners healthcare investment banking team has successfully guided hundreds of independent healthcare providers through private equity processes, with a strong focus on helping our clients find a partner that will set the practice up for long-term success in their healthcare private equity journey.

Our team at Physician Growth Partners focuses on a number of key areas to ensure our clients are successful in the pursuit of a healthcare private equity partner:

  • Develop the appropriate financial modeling to position maximized cash flow and future “credit” for ongoing initiatives that are driving growth
  • Determine the right mix of potential buyers (including both strategic acquirers and private equity groups) and implement a strategy to reach them
  • Managing buyer marketing, bid solicitation, and negotiation
  • Position the client to meet relevant potential buyers with strong offers that address cultural fit, strategy, and alignment
  • Manage the transaction process to maximize leverage with potential buyers
  • Assist client in running a full due-diligence process on buyers to ensure the best partner is selected
  • Negotiate key economic and structural deal terms, leveraging PGP experience within the Provider-Led healthcare services space
  • Facilitate all pre-closing due diligence to ensure a seamless process that does not take away from the day-to-day business while ensuring the highest probability for a successful close


Recent Relevant Transactions

Client Testimonial

I’m incredibly grateful for, and extremely satisfied with, the work that Michael Kroin and PGP did on my behalf. Not only did they knock it out of the park in terms of valuation, but they handled many other key details throughout the process. They kept me constantly informed and I truly felt they had my best interest in mind.

Dr. Kafele T. Hodari

Rejuvene from Hodari MD

Learn More About ENT & Allergy Private Equity

Name(Required)